Kelsey files Form 144 to sell 4,071 RVMD shares

Stephen Michael Kelsey filed a Form 144 notice to sell 4,071 shares of Common Stock of Revolution Medicines.

Rhea-AI Filing Summary

Stephen Michael Kelsey filed a Form 144 notice to sell 4,071 shares of Common Stock of Revolution Medicines. The filing lists restricted stock unit grants dated 03/01/2023, 03/01/2024, and 03/01/2025 totaling 4,071 units. It also reports that 4,302 shares were sold on 03/17/2026 for $427,964.68.

Insights

Securities Compliance Attorney

Notice filed under Form 144 reports proposed resale and a recent sale by an affiliate.

The filing lists 4,071 restricted stock units scheduled for resale and records a prior sale of 4,302 shares on 03/17/2026 for $427,964.68. This is a procedural disclosure under resale rules.

Regulatory implications are routine: transactions reported on Form 144 permit brokered resale under SEC rules when conditions are met. Subsequent trading activity will appear in market or insider filings.

Key Figures

Registered/offered shares: 4,071 shares Shares sold (past 3 months): 4,302 shares Proceeds reported: $427,964.68

3 metrics

Registered/offered shares 4,071 shares Restricted stock unit grants dated 03/01/2023–03/01/2025

Shares sold (past 3 months) 4,302 shares Sale date 03/17/2026 for $427,964.68

Proceeds reported $427,964.68 Proceeds from 4,302-share sale on 03/17/2026

Key Terms

Restricted stock unit grant, Form 144, Securities Sold During The Past 3 Months

3 terms

Restricted stock unit grant financial

"Restricted stock unit grant | Issuer | 1272 | 03/01/2023"

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months | Common Stock | 03/17/2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Stephen Michael Kelsey report on Form 144 for RVMD?

He reported a notice to sell 4,071 shares of Common Stock and disclosed prior sales of 4,302 shares on 03/17/2026 for $427,964.68. The filing lists restricted stock unit grants from 03/01/2023–03/01/2025.

How many shares were sold in the past three months according to the filing?

The filing records a sale of 4,302 shares on 03/17/2026 with gross proceeds of $427,964.68. This is listed in the "Securities Sold During The Past 3 Months" section.

What restricted awards are listed in the Form 144?

The notice lists restricted stock unit grants dated 03/01/2023 (1,272 units), 03/01/2024 (1,635 units), and 03/01/2025 (1,164 units), totaling 4,071 units.

Does the Form 144 indicate who will receive sale proceeds?

The filing does not attach a proceeds recipient statement beyond stating the seller's name. The document lists the seller as Stephen Michael Kelsey; specific proceeds allocation is not detailed in the provided excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/15/2026 - 05:59 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001462808
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Revolution Medicines, Inc.
SEC File Number	001-39219
Address of Issuer	700 SAGINAW DR REDWOOD CITY CALIFORNIA 94063
Phone	650-481-6801
Name of Person for Whose Account the Securities are To Be Sold	Kelsey Stephen Michael
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	ETRADE Financial Corporation 3 Edison Drive Alpharetta GA 30005	4071	626404.77	212596462	06/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/01/2023	Restricted stock unit grant	Issuer			1272	03/01/2023	Services Rendered
Common Stock	03/01/2024	Restricted stock unit grant	Issuer			1635	03/01/2024	Services Rendered
Common Stock	03/01/2025	Restricted stock unit grant	Issuer			1164	03/01/2025	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Stephen Michael Kelsey c/o Revolution Medicines, Inc. 700 Saginaw Drive Redwood City CA 94063	Common Stock	03/17/2026	4302	427964.68

144: Remarks and Signature

Remarks
Date of Notice	06/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/31/2023
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Jack Anders, as Attorney-in-Fact for Stephen Michael Kelsey
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)